AMDD 提交「经济财政运营与改革基本方针 2026」的建议案
尚無 AI 分析資料。
常見問題
- Q: What is AMDD?
- A: AMDD stands for the American Medical Devices and Diagnostics Manufacturers’ Association. It is an industry association composed of companies primarily headquartered in the United States or conducting business in the United States that handle medical devices and in-vitro diagnostics (IVDs).
- Q: What is the "Basic Policy on Economic and Fiscal Management and Reform" (Honebuto Hoshin)?
- A: It is a fundamental policy document established by the Japanese government that outlines the basic direction for economic and fiscal management and reform for the upcoming fiscal year.
- Q: What are the main recommendations submitted by AMDD?
- A: AMDD's main recommendations include: 1. Flexible insurance reimbursement prices for medical devices and IVDs to address inflation. 2. International harmonization of regulations to resolve device lag and loss. 3. Promotion of digital health technologies for efficiency and reduced burden. 4. Systems for public access to correct information on medical devices and IVDs. 5. Promotion of secondary use of medical data and database linkage through public-private collaboration.
- Q: What is "device lag" and "device loss"?
- A: "Device lag" refers to the delay in the availability of new medical devices in Japan compared to other developed countries. "Device loss" can refer to situations where Japan misses out on the development or adoption of innovative medical technologies.
- Q: Why is AMDD advocating for flexible insurance reimbursement prices?
- A: AMDD is advocating for flexible pricing to address continuous cost increases due to inflation (price and wage hikes) and to resolve the issue of "negative margins" where medical institutions' purchase prices exceed reimbursement prices, ensuring fair compensation for medical device costs.